Ntontsi P - Search Results

1

Targeted anti-IL-13 therapies in asthma: current data and future perspectives.

Ntontsi P, Papathanassiou E, Loukides S, Bakakos P, Hillas G. Ntontsi P, et al. Expert Opin Investig Drugs. 2018 Feb;27(2):179-186. doi: 10.1080/13543784.2018.1427729. Epub 2018 Jan 19. Expert Opin Investig Drugs. 2018. PMID: 29334288 Review.

2

Biomarkers Guided Treatment Strategies in Adult Patients with Asthma: Ready for the Clinical Field?

Tsilogianni Z, Ntontsi P, Papaioannou AI, Bakakos P, Loukides S. Tsilogianni Z, et al. Among authors: ntontsi p. Arch Immunol Ther Exp (Warsz). 2017 Feb;65(1):1-9. doi: 10.1007/s00005-016-0407-9. Epub 2016 Jun 8. Arch Immunol Ther Exp (Warsz). 2017. PMID: 27271573 Free article. Review.

3

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

Konstantellou E, Loukides S, Ntontsi P, Papathanasiou E, Kostikas K, Paptheodorou G, Hillas G, Papiris S, Koulouris NG, Bakakos P. Konstantellou E, et al. Among authors: ntontsi p. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1129-1131.e3. doi: 10.1016/j.jaip.2017.03.005. Epub 2017 Apr 7. J Allergy Clin Immunol Pract. 2017. PMID: 28396112 No abstract available.

4

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.

Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, Hillas G, Koulouris N, Papiris S, Papaioannou AI. Ntontsi P, et al. Allergy. 2017 Nov;72(11):1761-1767. doi: 10.1111/all.13184. Epub 2017 May 11. Allergy. 2017. PMID: 28407269

5

Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.

Kallieri M, Papaioannou AI, Papathanasiou E, Ntontsi P, Papiris S, Loukides S. Kallieri M, et al. Among authors: ntontsi p. Postgrad Med. 2017 Aug;129(6):598-604. doi: 10.1080/00325481.2017.1321945. Epub 2017 Apr 28. Postgrad Med. 2017. PMID: 28427296

6

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms.

Ntontsi P, Bakakos P, Papathanasiou E, Tsilogianni Z, Kostikas K, Hillas G, Papatheodorou G, Koulouris N, Papiris S, Loukides S. Ntontsi P, et al. J Breath Res. 2018 Feb 20;12(2):026013. doi: 10.1088/1752-7163/aa9d46. J Breath Res. 2018. PMID: 29176061

7

Experimental and investigational phosphodiesterase inhibitors in development for asthma.

Ntontsi P, Detta A, Bakakos P, Loukides S, Hillas G. Ntontsi P, et al. Expert Opin Investig Drugs. 2019 Mar;28(3):261-266. doi: 10.1080/13543784.2019.1571582. Epub 2019 Jan 24. Expert Opin Investig Drugs. 2019. PMID: 30678501 Review.

8

Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

Papathanasiou E, Bakakos P, Hillas G, Ntontsi P, Blizou M, Kostikas K, Koulouris N, Papiris S, Loukides S. Papathanasiou E, et al. Among authors: ntontsi p. J Allergy Clin Immunol Pract. 2020 Jan;8(1):385-387.e2. doi: 10.1016/j.jaip.2019.05.052. Epub 2019 Jun 13. J Allergy Clin Immunol Pract. 2020. PMID: 31257188 No abstract available.

9

Severe asthma: what is new in the new millennium.

Ntontsi P, Samitas K, Zervas E, Gaga M. Ntontsi P, et al. Curr Opin Allergy Clin Immunol. 2020 Apr;20(2):202-207. doi: 10.1097/ACI.0000000000000623. Curr Opin Allergy Clin Immunol. 2020. PMID: 32004177 Review.

10

EBC metabolomics for asthma severity.

Ntontsi P, Ntzoumanika V, Loukides S, Benaki D, Gkikas E, Mikros E, Bakakos P. Ntontsi P, et al. J Breath Res. 2020 Jul 3;14(3):036007. doi: 10.1088/1752-7163/ab9220. J Breath Res. 2020. PMID: 32392552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page